These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15167989)

  • 21. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
    Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of treatment benefit due to low compliance with bisphosphonate therapy.
    Penning-van Beest FJ; Erkens JA; Olson M; Herings RM
    Osteoporos Int; 2008 Apr; 19(4):511-7. PubMed ID: 17874028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures.
    Liel Y; Castel H; Bonneh DY
    Osteoporos Int; 2003 Jul; 14(6):490-5. PubMed ID: 12730761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful direct intervention for osteoporosis in patients with minimal trauma fractures.
    Kuo I; Ong C; Simmons L; Bliuc D; Eisman J; Center J
    Osteoporos Int; 2007 Dec; 18(12):1633-9. PubMed ID: 17603741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models.
    Zambon A; Baio G; Mazzaglia G; Merlino L; Corrao G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):260-9. PubMed ID: 18240162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.
    Schousboe JT; Taylor BC; Fink HA; Kane RL; Cummings SR; Orwoll ES; Melton LJ; Bauer DC; Ensrud KE
    JAMA; 2007 Aug; 298(6):629-37. PubMed ID: 17684185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up treatment for osteoporosis after fracture.
    Hooven F; Gehlbach SH; Pekow P; Bertone E; Benjamin E
    Osteoporos Int; 2005 Mar; 16(3):296-301. PubMed ID: 15221208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women.
    Lin TC; Yang CY; Yang YH; Lin SJ
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4717-26. PubMed ID: 24081731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
    J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
    Jaglal SB; Weller I; Mamdani M; Hawker G; Kreder H; Jaakkimainen L; Adachi JD
    J Bone Miner Res; 2005 Jun; 20(6):898-905. PubMed ID: 15883628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
    Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
    J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.
    Stone KL; Seeley DG; Lui LY; Cauley JA; Ensrud K; Browner WS; Nevitt MC; Cummings SR;
    J Bone Miner Res; 2003 Nov; 18(11):1947-54. PubMed ID: 14606506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.
    Siris ES; Harris ST; Rosen CJ; Barr CE; Arvesen JN; Abbott TA; Silverman S
    Mayo Clin Proc; 2006 Aug; 81(8):1013-22. PubMed ID: 16901023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary.
    Lakatos P; Takács I; Marton I; Tóth E; Zoltan C; Lang Z; Psachoulia E; Intorcia M
    Calcif Tissue Int; 2016 Mar; 98(3):215-25. PubMed ID: 26686694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures.
    Giangregorio LM; Leslie WD;
    J Bone Miner Res; 2010 Jun; 25(6):1400-5. PubMed ID: 20200950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.